ERA-63

Rheumatoid Arthritis (RA) Pipeline Insight Report 2020 Featuring 10 Key Players & 12 Products - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 11, 2020

The "Rheumatoid Arthritis (RA) - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Rheumatoid Arthritis (RA) - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This "Rheumatoid Arthritis - Pipeline Insight, 2020" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Rheumatoid Arthritis pipeline landscape.
  • HB-adMSCs have already been used as a safe and effective treatment in a Phase I/IIa clinical trial for Rheumatoid Arthritis.
  • This segment of the report provides insights about the different Rheumatoid Arthritis drugs segregated based on following parameters that define the scope of the report.

United States Rheumatoid Arthritis Market and Competitive Landscape Report 2020: Epidemiology, Key Products Marketed, Market Valuations and Forecast, Drugs Sales and Market Shares 2016-2025 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 18, 2020

US Rheumatoid Arthritis Market and Competitive Landscape Highlights - 2020, provides comprehensive insights into Rheumatoid Arthritis pipeline products, Rheumatoid Arthritis epidemiology, Rheumatoid Arthritis market valuations and forecast, Rheumatoid Arthritis drugs sales and competitive landscape in the US.

Key Points: 
  • US Rheumatoid Arthritis Market and Competitive Landscape Highlights - 2020, provides comprehensive insights into Rheumatoid Arthritis pipeline products, Rheumatoid Arthritis epidemiology, Rheumatoid Arthritis market valuations and forecast, Rheumatoid Arthritis drugs sales and competitive landscape in the US.
  • The research is classified into seven sections - Rheumatoid Arthritis treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
  • Rheumatoid Arthritis pipeline: Find out the products in clinical trials for the treatment of Rheumatoid Arthritis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
    Rheumatoid Arthritis drugs: Identify key products marketed and prescribed for Rheumatoid Arthritis in the US, including trade name, molecule name, and company
    Rheumatoid Arthritis market valuations: Find out the market size for Rheumatoid Arthritis drugs in 2019 in the US.
  • Find out how the market advanced from 2016 and forecast to 2025
    Rheumatoid Arthritis drugs market share: Find out the market shares for key Rheumatoid Arthritis drugs in the US
    Evaluate commercial market opportunity assessment, positioning, and segmentation for Rheumatoid Arthritis products

Global Rheumatoid Arthritis Clinical Trial Pipeline Report 2019-2024 - Track Competition, Identifying Partners, & Evaluate Opportunities

Retrieved on: 
Wednesday, June 12, 2019

DUBLIN, June 12, 2019 /PRNewswire/ -- The "Global Rheumatoid Arthritis Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 12, 2019 /PRNewswire/ -- The "Global Rheumatoid Arthritis Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.
  • Rheumatoid Arthritis Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Rheumatoid Arthritis market.
  • It covers emerging therapies for Rheumatoid Arthritis in active clinical development stages including early and late stage clinical trials.
  • The report provides Rheumatoid Arthritis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Rheumatoid Arthritis Clinical Trial Pipeline Highlights, 2019-2024 - Clinical Trial Stages, Drug Mechanism Classes, Companies & Short-term Launch Highlights - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 5, 2019

The "Global Rheumatoid Arthritis Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Rheumatoid Arthritis Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.
  • Rheumatoid Arthritis Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Rheumatoid Arthritis market.
  • It covers emerging therapies for Rheumatoid Arthritis in active clinical development stages including early and late stage clinical trials.
  • The report provides Rheumatoid Arthritis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.